🇺🇸 FDA
Patent

US 7837999

Method of increasing muscle mass with IGF-1 fusion polypeptides

granted A61KA61K38/30A61P

Quick answer

US patent 7837999 (Method of increasing muscle mass with IGF-1 fusion polypeptides) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/30, A61P, A61P19/10, A61P21/00